scholarly article | Q13442814 |
P50 | author | Bruce M. Psaty | Q30429993 |
Susan R Heckbert | Q88077554 | ||
P2093 | author name string | Siscovick DS | |
Grayston JT | |||
Jackson LA | |||
Smith NL | |||
P2860 | cites work | Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 |
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women | Q38510705 | ||
Alternative hypothesis for efficacy of macrolides in acute coronary syndromes | Q43429541 | ||
P433 | issue | 2 | |
P921 | main subject | erythromycin | Q213511 |
doxycycline | Q422442 | ||
tetracycline | Q193045 | ||
myocardial infarction | Q12152 | ||
P304 | page(s) | 281-284 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Emerging Infectious Diseases | Q5235761 |
P1476 | title | Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline | |
P478 | volume | 5 |
Q35917262 | Advances in the management of Chlamydia pneumoniae infections |
Q35587190 | Antibiotic treatment of atherosclerosis |
Q37873319 | Antibiotic use and risk of ischemic stroke in the elderly |
Q37863427 | Antibiotics active against Chlamydia do not reduce the risk of myocardial infarction |
Q33935098 | Antibiotics in the prevention and treatment of coronary heart disease |
Q33935003 | Background and current knowledge of Chlamydia pneumoniae and atherosclerosis |
Q51726841 | Chlamydia pneumoniae and Cardiovascular Disease. |
Q33905858 | Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies |
Q62279926 | Chlamydia pneumoniae and atherosclerotic cardiovascular disease |
Q37876040 | Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study |
Q37875263 | Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship? |
Q79299394 | Chronic infection and coronary artery disease |
Q34514051 | Chronic infections and atherosclerosis/thrombosis |
Q44772269 | Effect of tetracyclines on the development of vascular disease in veterans with acne or rosacea: a retrospective cohort study |
Q33987842 | Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. |
Q34562273 | Evidence for infectious agents in cardiovascular disease and atherosclerosis |
Q43427569 | Genitourinary chlamydial infection: a reappraisal and hypothesis |
Q33921219 | Infections and atherosclerosis |
Q36342810 | Managing Cardiovascular Risk of Macrolides: Systematic Review and Meta-Analysis. |
Q37876321 | Past use of erythromycin, tetracycline, or doxycycline is not associated with risk of first myocardial infarction |
Q38097947 | Periodontal disease and systemic illness: will the evidence ever be enough? |
Q37872836 | Relation of antibiotic use to risk of myocardial infarction in the general population |
Q34874476 | Role of antibiotics for the prevention of cardiovascular disease |
Q34075142 | The association of infection and coronary artery disease: an update |
Q33770472 | The possible role of infections in acute myocardial infarction |
Search more.